Mitral Stenosis Evaluation and Cardiac Function Analysis

Mitral stenosis, most often of rheumatic origin, imposes a progressive obstruction to left atrial outflow, leading to raised atrial pressures, pulmonary hypertension and eventual right ventricular compromise. Precise evaluation requires integration of anatomical imaging—typically two-dimensional and Doppler echocardiography—with functional indices such as valve area, mean gradient and pressure half-time. Emerging techniques, notably speckle tracking echocardiography and cardiac magnetic resonance, permit quantification of myocardial deformation, global longitudinal strain and ventricular torsion, revealing subtle systolic and diastolic dysfunction even when conventional ejection fraction appears preserved. Percutaneous balloon valvuloplasty remains the mainstay intervention, and serial assessment of right and left ventricular strain patterns helps to gauge procedural success and predict long-term remodelling. A comprehensive approach that combines structural, haemodynamic and myocardial mechanics is now recognised as essential to guide timing of intervention and to optimise outcomes.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

Recent studies have applied speckle tracking to assess immediate and mid-term changes in ventricular mechanics following percutaneous balloon mitral valvuloplasty. One investigation demonstrated prompt improvement in right ventricular global longitudinal strain and pulmonary function parameters within 48 hours and up to 15 days post-procedure, highlighting relief of afterload and enhanced ventricular performance. A longitudinal magnetic resonance series evaluated left ventricular volumes, ejection fraction and both global longitudinal and circumferential strain before, six months and one year after valvuloplasty. Findings revealed progressive augmentation of myocardial strain indices and modest reduction in end-systolic volume, suggesting ongoing reverse remodelling. Most recently, a two-dimensional speckle tracking study compared patients with severe mitral stenosis and preserved ejection fraction against healthy controls, uncovering significant reductions in segmental and global longitudinal strain in basal and mid-ventricular segments. These collective insights underscore the role of deformation imaging in detecting subclinical dysfunction, monitoring therapeutic impact and refining risk stratification.

Mitral Stenosis Evaluation and Cardiac Function Analysis publication trend

The graph below shows the total number of articles in mitral stenosis evaluation and cardiac function analysis across all publications each year (not limited to Nature Index journals).

Technical terms

Valve area: Cross-sectional orifice of the mitral valve, typically measured by planimetry or pressure half-time.

Speckle tracking echocardiography: An imaging technique that analyses natural acoustic markers to quantify myocardial deformation and strain.

Global longitudinal strain (GLS): Average percentage change in myocardial length along the long axis during systole, indicating systolic function.

Cardiac magnetic resonance (CMR): High-resolution imaging modality used to measure ventricular volumes, function and tissue characteristics.

Percutaneous balloon mitral valvuloplasty (PBMV): A minimally invasive procedure in which a balloon catheter is used to dilate a stenotic mitral valve.

References

1. Assessment of immediate effects of percutaneous balloon mitral valvuloplasty on right ventricular and pulmonary functions in severe rheumatic mitral stenosis patients using speckle tracking echocardiography and spirometry. Journal of Cardiovascular and Thoracic Research (2020).
2. Left Ventricular Remodeling Following Balloon Mitral Valvuloplasty in Rheumatic Mitral Stenosis: Magnetic Resonance Imaging Study. Frontiers in Cardiovascular Medicine (2021).
3. Segmental and global longitudinal strain measurement by 2-dimensional speckle tracking echocardiography in severe rheumatic mitral stenosis. BMC Cardiovascular Disorders (2023).